Tasimelteon(CAS: 609799-22-6)

Tasimelteon (CAS: 609799-22-6) is a melatonin receptor agonist. It is a white or pale yellow crystalline powder with a molecular weight of approximately 348.35 g/mol. The compound is slightly soluble in water and ethanol. It has a high chemical stability and is not reactive under normal conditions. Tasimelteon is primarily used in the treatment of circadian rhythm disorders, particularly in patients with non-24-hour sleep-wake disorder.

Tasimelteon (CAS: 609799-22-6) is synthesized through a multistep process involving several key reactions. The synthesis typically starts with a readily available starting material, such as 2-aminobenzaldehyde, which undergoes multiple functional group transformations. Common synthetic routes involve protective group strategies, selective aminomethylation, and catalytic hydrogenation. The final product is obtained with good to excellent yield, often requiring column chromatography for purification.

Tasimelteon (CAS: 609799-22-6) is primarily used in the pharmaceutical industry. It is approved by the FDA for the treatment of circadian rhythm sleep disorders, specifically non-24-hour sleep-wake disorder in blind individuals. While not directly used in other industries like polymers or sensors, its synthesis and use involve advancements in chemical and pharmaceutical sciences.

When handling Tasimelteon (CAS: 609799-22-6), it is important to follow standard laboratory safety protocols. Wear appropriate personal protective equipment, including gloves and safety goggles. Work in a well-ventilated area or a fume hood to minimize exposure. Avoid contact with skin and eyes. In case of a spill, immediately clean up using appropriate methods and consult the Material Safety Data Sheet (MSDS) for further guidance. Ensure proper storage in a cool, dry place away from direct sunlight and moisture.